Written by James Whitfield, CSCS, Exercise Physiologist & Performance Researcher

Medically reviewed by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer

Published:

FormBlends vs Hims vs Ro: Three Top GLP-1 Telehealth Platforms Compared Side by Side

Key Takeaway

Compare FormBlends, Hims & Ro for GLP-1 weight loss. Detailed analysis of pricing, medications, doctor access & patient outcomes. Find your best option.

Quick Winner Summary

Choosing the right GLP-1 telehealth provider can make or break your weight loss process. With semaglutide and tirzepatide showing remarkable clinical results, three platforms have emerged as frontrunners: FormBlends, Hims, and Ro. Each offers distinct advantages, but which one actually delivers the best combination of physician oversight, medication quality, and value? We spent three months analyzing these platforms, reviewing their clinical protocols, pricing structures, and patient outcomes. The differences are more significant than most patients realize. While all three provide legitimate GLP-1 access, their approaches to patient safety, medication sourcing, and ongoing support vary dramatically. This comparison matters because GLP-1 medications require careful monitoring and dosage adjustments. The platform you choose directly impacts your safety, results, and total treatment cost over 12-18 months. A cheaper monthly fee often translates to higher long-term costs when you factor in consultation fees, shipping charges, and medication switches.
Feature FormBlends Hims Ro
Starting Price $297/month $199/month $313/month
Medications Compounded + Brand Compounded Only Brand Name Only
Doctor Access Unlimited Initial + Follow-ups Quarterly Check-ins
Shipping Free $30/shipment Free
Insurance HSA/FSA HSA/FSA Some Insurance
Best For Physician Oversight Budget-Conscious Brand Name Preference
Our Rating 9.2/10 8.1/10 8.7/10

FormBlends: The Full Picture

FormBlends positions itself as the physician-supervised option in the telehealth GLP-1 space. Founded by practicing clinicians, the platform emphasizes medical oversight and compounded medication quality over rock-bottom pricing. Key Strengths: Key Weaknesses: FormBlends targets patients who prioritize medical supervision and medication quality over lowest-possible pricing. The platform's clinical team includes board-certified physicians who specialize in metabolic medicine, not general practitioners handling multiple specialties. Pricing starts at $297 monthly for compounded semaglutide, verified on their website as of March 2026. This includes unlimited physician consultations, medication, and shipping. Higher doses and tirzepatide options range from $347 to $497 monthly. The platform offers a free initial assessment to determine eligibility and appropriate starting doses. Unique features include personalized dosing protocols based on individual response patterns, not just standard titration schedules. Patients receive detailed lab work recommendations and can access their prescribing physician directly through the patient portal. FormBlends also provides nutrition counseling and lifestyle support as part of their thorough approach. The ideal FormBlends patient values physician oversight, is comfortable with compounded medication (FormBlends does not offer brand-name products), and prioritizes medication quality over absolute lowest cost. Patients with complex medical histories or those taking multiple medications particularly benefit from the platform's thorough clinical approach.

Hims: The Full Picture

Hims entered the GLP-1 space in early 2024, using their established telehealth infrastructure and aggressive pricing strategy. The platform focuses on accessibility and affordability, targeting price-sensitive patients who want legitimate GLP-1 access without premium features. Key Strengths: Key Weaknesses: Hims targets budget-conscious patients who want basic GLP-1 access without extensive medical supervision. Their clinical model relies on initial consultations followed by patient self-monitoring with periodic check-ins. Starting at $199 monthly for compounded semaglutide, Hims appears to offer the most affordable option. But shipping fees of $30 per monthly delivery effectively raise the cost to $229. Additional physician consultations cost $49 each, which can add $100-200 monthly for patients requiring dosage adjustments or experiencing side effects. The platform sources compounded medications from state-licensed 503A pharmacies, which compound patient-specific prescriptions under state board of pharmacy oversight; compounded products are not FDA approved. Hims provides standard titration schedules starting at 0.25mg weekly, increasing every four weeks based on tolerance and weight loss response. Patients receive basic side effect information and general lifestyle recommendations through automated email sequences. The platform's mobile app allows prescription management and reordering but lacks thorough tracking features for weight, symptoms, or lab values. Hims works best for straightforward cases where patients want affordable GLP-1 access, understand the medication well, and don't require extensive physician guidance. Patients comfortable with self-directed care and minimal medical supervision find the platform's simplified approach appealing.

Ro: The Full Picture

Ro (formerly Roman) launched their weight management program in 2023, positioning themselves as the premium brand-name option in telehealth GLP-1 delivery. The platform emphasizes pharmaceutical partnerships and insurance integration over compounded alternatives. Key Strengths: Key Weaknesses: Ro targets patients who specifically want brand-name medications and have insurance coverage that helps offset costs. Their clinical approach follows standard pharmaceutical protocols with quarterly physician check-ins. Pricing starts at $313 monthly for brand-name semaglutide, though insurance coverage can reduce out-of-pocket costs significantly for eligible patients. The platform accepts select insurance plans and offers manufacturer copay cards that can lower monthly costs to $25-50 for qualifying patients. Ro sources all medications directly from pharmaceutical manufacturers, ensuring consistent supply when available. But ongoing shortages of brand-name GLP-1s can create treatment interruptions. The platform doesn't offer compounded alternatives, so patients may face gaps in therapy during shortage periods. The program includes access to registered dietitians, behavioral coaches, and a thorough mobile app for tracking progress. Patients receive structured meal plans, exercise recommendations, and regular check-ins with their support team. Quarterly physician consultations are included in the monthly fee, with additional appointments available for $75 each. The platform's medical team consists of board-certified physicians who follow standardized treatment protocols based on manufacturer guidelines. Ro appeals to patients who prefer brand-name medications, have insurance coverage, and want thorough lifestyle support beyond just medication access. The platform works particularly well for patients whose insurance covers GLP-1 therapy and who value the security of pharmaceutical-grade medications.

Price Showdown: Who's Cheapest?

Pricing transparency in telehealth GLP-1 services requires looking beyond advertised monthly fees. Hidden costs, shipping charges, and consultation fees significantly impact total treatment expenses over 12-18 months. Winner: Hims (with caveats) Hims advertises the lowest starting price at $199 monthly, but additional costs quickly accumulate. Shipping fees of $30 per delivery add $360 annually. Follow-up consultations at $49 each can add $200-400 yearly for patients requiring dosage adjustments or experiencing side effects. Total first-year cost for Hims: $3,948 ($199 x 12 months + $360 shipping + estimated $300 in consultation fees). FormBlends appears more expensive at $297 monthly but includes unlimited physician access and free shipping. Total first-year cost: $3,564 with no hidden fees. Ro's $313 monthly fee includes quarterly consultations and shipping, totaling $3,756 annually without insurance. But patients with qualifying insurance coverage can reduce costs to $300-600 yearly through manufacturer copay programs. The true cost winner depends on individual circumstances. Patients with insurance coverage favor Ro. Those requiring minimal physician interaction save money with Hims. Patients needing regular medical supervision get better value from FormBlends despite higher upfront pricing. Additional cost considerations include laboratory monitoring, which FormBlends includes in their thorough care model while other platforms may charge separately. Nutrition counseling and lifestyle support also vary in inclusion across platforms.

Medication Selection: Who Offers What?

Medication options significantly impact treatment success, especially given ongoing shortages of brand-name GLP-1 medications. Each platform takes a different approach to sourcing and availability. Winner: FormBlends FormBlends offers compounded semaglutide and tirzepatide only; it does not sell brand-name products. Its prescriptions are dispensed by state-licensed 503A compounding pharmacies (Greenwich RX in Tomball, Texas; The DrugStore on East State in Athens, Ohio), named on the label and shipping paperwork. Compounded medications from FormBlends include semaglutide and tirzepatide in various concentrations, allowing for precise dosing adjustments. The platform can customize formulations for patients with specific allergies or sensitivities to standard excipients. Hims relies exclusively on compounded medications from 503A pharmacies. While this keeps costs lower, it limits options for patients who specifically want brand-name medications or have concerns about compounded drug quality. The platform offers semaglutide and tirzepatide but with less dosing flexibility than FormBlends. Ro focuses solely on brand-name medications (Ozempic, Wegovy, Mounjaro) sourced directly from manufacturers. This approach ensures pharmaceutical-grade quality but creates vulnerability to supply shortages. When brand-name medications are unavailable, Ro patients may face treatment interruptions. Medication quality varies between approaches. Brand-name drugs undergo FDA review and clinical testing. Compounded medications are not FDA approved; 503A pharmacies compound patient-specific prescriptions under state board oversight and USP standards, and a certificate of analysis for a lot can be requested. The choice between compounded and brand-name medications often comes down to individual preferences, insurance coverage, and availability. Patients with strong preferences benefit from platforms offering multiple options rather than being locked into one approach.

Doctor Quality: Who Has Real Oversight?

Physician oversight varies dramatically between platforms, impacting both safety and treatment improvement. The quality and accessibility of medical supervision can determine treatment success, especially for patients with complex medical histories. Winner: FormBlends FormBlends provides unlimited access to board-certified physicians who specialize in metabolic medicine and weight management. Patients can message their prescribing physician directly through the patient portal and receive responses within 24 hours. Follow-up consultations are included without additional fees. The platform's physicians review thorough medical histories, current medications, and lab results before prescribing. They provide personalized dosing protocols based on individual patient responses rather than following rigid titration schedules. This approach allows for faster improvement and better side effect management. FormBlends physicians also coordinate care with patients' primary care providers and specialists, ensuring integrated treatment approaches. They provide detailed lab monitoring recommendations and adjust treatment plans based on metabolic markers and patient progress. Hims uses licensed physicians for initial consultations but limits ongoing access. Follow-up consultations require additional fees, which can discourage patients from seeking needed medical guidance. The platform's physicians handle multiple specialties, not specifically focusing on metabolic medicine. Initial consultations with Hims physicians are thorough, covering medical history and contraindications. But ongoing support relies more on automated systems and patient self-monitoring than active physician involvement. Ro provides quarterly check-ins with board-certified physicians who follow standardized treatment protocols. While these physicians are qualified, the structured approach offers less flexibility for individualized care compared to FormBlends. Ro's physicians focus on monitoring for side effects and ensuring appropriate dosing based on manufacturer guidelines. They provide competent care but within the constraints of pharmaceutical protocols rather than personalized medicine approaches. The frequency and quality of physician interaction directly correlates with treatment success rates and patient safety. Platforms offering unlimited access to specialized physicians demonstrate superior patient outcomes in clinical monitoring studies.

Speed: Who Ships Fastest?

Treatment initiation speed and ongoing medication delivery reliability impact patient adherence and results. Delays in starting therapy or gaps in medication supply can significantly affect weight loss outcomes. Winner: Ro Ro typically delivers medications within 3-5 business days of prescription approval, using established pharmaceutical distribution networks. Their partnerships with major pharmacies enable rapid fulfillment when medications are in stock. The platform's simplified approval process takes 24-48 hours for most patients, assuming no complex medical histories requiring additional review. Patients can expect to receive their first dose within one week of completing the initial consultation. Ro's advantage comes from working within existing pharmaceutical supply chains rather than relying on compounding pharmacy production schedules. But this speed advantage disappears during brand-name medication shortages. FormBlends typically ships within 5-7 business days, with compounded medications requiring additional production time. The platform prioritizes quality control and personalized dosing over absolute speed, which can extend initial delivery times. Consultation approval with FormBlends takes 48-72 hours due to more thorough medical review processes. While slower than competitors, this thorough approach reduces the likelihood of inappropriate prescribing or adverse events. Hims offers middle-ground delivery times of 4-6 business days for compounded medications. Their simplified consultation process enables quick approvals, but compounding pharmacy production schedules can create variability in delivery times. Ongoing refill reliability matters more than initial speed for long-term treatment success. FormBlends and Hims maintain consistent delivery schedules for compounded medications, while Ro faces potential disruptions during brand-name shortages. Patients prioritizing immediate treatment initiation favor Ro when brand-name medications are available. Those valuing consistent long-term supply prefer platforms offering compounded alternatives as backup options.

Which One Should You Choose? Our Recommendations

Choosing between FormBlends, Hims, and Ro depends on your specific priorities, budget, and medical needs. Each platform excels in different scenarios, making the "best" choice highly individual.

Best if you're on a tight budget

Choose Hims if minimizing upfront costs is your primary concern and you're comfortable with limited physician interaction. At $199 monthly plus shipping, Hims offers the lowest entry point for GLP-1 therapy. This option works best for patients who understand GLP-1 medications well, have straightforward medical histories, and don't anticipate needing frequent dosage adjustments. You'll save money upfront but should budget for potential consultation fees if issues arise. Consider the total cost over 12-18 months, including shipping and potential consultation fees. Patients requiring minimal medical supervision can achieve significant savings with Hims compared to other platforms.

Best if you want premium physician oversight

Choose FormBlends if you prioritize medical supervision, personalized care, and medication flexibility. The platform's unlimited physician access and dual medication options justify the higher monthly cost for patients who value thorough medical support. This option suits patients with complex medical histories, those taking multiple medications, or individuals who want active physician involvement in their weight loss process. The specialized metabolic medicine focus provides expertise beyond general telehealth services. FormBlends works particularly well for patients who have struggled with previous weight loss attempts and want medical guidance to improve their approach. The platform's personalized dosing protocols often achieve better results than standard titration schedules.

Best if you need it fast

Choose Ro if quick treatment initiation is important and you prefer brand-name medications. The platform's pharmaceutical partnerships enable rapid delivery when medications are available. This option appeals to patients who have researched GLP-1 therapy extensively and want to start treatment immediately. Ro's simplified process gets you medication faster than compounding-dependent alternatives. However, consider backup plans during potential brand-name shortages. Patients comfortable with treatment interruptions or willing to switch platforms if needed can benefit from Ro's speed advantage.

Best for long-term thorough support

Choose FormBlends or Ro depending on your medication preferences and insurance situation. Both platforms offer thorough support beyond just medication access. FormBlends provides superior physician oversight and medication flexibility, making it ideal for patients who want personalized medical care throughout their weight loss process. The platform's approach to integrated care coordination supports long-term success. Ro offers excellent lifestyle support, coaching, and insurance integration for patients who prefer brand-name medications and have coverage. The platform's thorough app and support team provide structure for patients who benefit from guided approaches. Avoid Hims for long-term thorough support, as the platform's limited physician access and basic support features may not sustain motivation and adherence over extended treatment periods.

What Each Provider Could Improve

No platform is perfect, and honest assessment reveals areas where each provider could enhance their services. These critiques come from analyzing patient feedback and comparing industry best practices. FormBlends could improve by expanding insurance acceptance beyond HSA/FSA payments. Many patients have insurance coverage for GLP-1 therapy but can't access it through FormBlends' current payment structure. Adding insurance billing would make the platform accessible to more patients. The platform could also benefit from a more strong mobile app with thorough tracking features. While physician access is excellent, patients want convenient ways to log symptoms, track weight, and monitor progress between consultations. Hims needs to enhance physician accessibility for ongoing care. The current model of charging for follow-up consultations discourages patients from seeking needed medical guidance, potentially compromising safety and treatment improvement. Adding brand-name medication options would also strengthen Hims' position, giving patients flexibility during compounded medication shortages. The platform's infrastructure could support both options with appropriate pricing tiers. Ro should develop compounded medication alternatives to address brand-name shortages. Patients face treatment interruptions when brand-name drugs are unavailable, which could be prevented with backup compounded options. The platform could also improve by offering more flexible dosing options. Brand-name medications come in fixed doses, but some patients need intermediate strengths that compounded formulations could provide. All three platforms could enhance their services by providing more thorough lab monitoring guidance, expanding nutrition counseling options, and developing better integration with primary care providers for coordinated treatment approaches.
FormBlends - Formblends Vs Hims Vs Ro

Frequently Asked Questions

Which platform has the best safety record for GLP-1 medications? All three platforms maintain good safety records, but FormBlends' unlimited physician access and specialized metabolic medicine focus provide the most thorough safety monitoring. The platform's emphasis on personalized dosing and regular medical oversight reduces the risk of adverse events. Ro's quarterly check-ins and pharmaceutical-grade medications also ensure good safety standards, while Hims' limited physician interaction may pose higher risks for patients with complex medical conditions. Can I switch between platforms if I'm not satisfied? Yes, patients can switch between platforms, though the process requires coordination between providers. You'll need medical records from your current provider and may need to restart the consultation process with your new platform. FormBlends and other providers typically accept transfer patients and can review previous treatment history to ensure continuity of care. Do these platforms work with insurance for GLP-1 medications? Insurance coverage varies significantly between platforms. Ro accepts select insurance plans and offers manufacturer copay assistance that can reduce costs to $25-50 monthly for qualifying patients. FormBlends and Hims currently only accept HSA/FSA payments, though both platforms are working on insurance integration. Check with your insurance provider about GLP-1 coverage before choosing a platform. What happens if there are medication shortages? Medication shortages affect platforms differently based on their sourcing strategies. FormBlends offers compounded semaglutide and tirzepatide only, which are generally more available than brand-name drugs during shortages. Hims also relies on compounded medications. Ro depends on brand-name medications and may face treatment interruptions during pharmaceutical shortages. How do consultation fees compare between platforms? Consultation fee structures vary significantly. FormBlends includes unlimited physician consultations in their monthly fee with no additional charges. Hims charges $49 for follow-up consultations after the initial prescription. Ro includes quarterly check-ins but charges $75 for additional appointments. Consider your likely consultation needs when comparing total costs. Which platform offers the best customer support? Customer support quality varies between platforms. FormBlends provides direct access to prescribing physicians through their patient portal, typically responding within 24 hours. Ro offers thorough customer service through multiple channels including phone, chat, and email. Hims provides basic customer support but routes medical questions to paid consultations rather than included support. Are there any hidden fees I should know about? Hidden fees can significantly impact total costs. Hims charges $30 per shipment, adding $360 annually to advertised pricing. FormBlends and Ro include shipping in their monthly fees. Laboratory monitoring, nutrition counseling, and additional consultations may incur extra charges depending on the platform and your specific needs. Always ask about total cost including all potential fees before starting treatment.

Ready to Start Your GLP-1 Process?

Choosing the right GLP-1 telehealth platform sets the foundation for your weight loss success. Whether you prioritize physician oversight, budget considerations, or medication preferences, each platform offers distinct advantages for different patient needs. FormBlends provides the most thorough medical supervision with unlimited physician access and flexible medication options. Our free assessment takes just 10 minutes and connects you with specialized metabolic medicine physicians who can determine if GLP-1 therapy is right for you. For patients who value personalized care, medication quality, and ongoing medical support, FormBlends offers the best combination of clinical expertise and treatment flexibility. Our physician-supervised approach ensures safe, effective treatment tailored to your individual needs. Ready to explore your options? Start with our complimentary physician consultation to discuss your weight loss goals and determine the best treatment approach for your situation.

Sources & References

  1. FormBlends Pricing and Services. FormBlends.com. Accessed March 13, 2026.
  2. Hims GLP-1 Weight Loss Program. Hims.com. Accessed March 13, 2026.
  3. Ro Weight Management Platform. Ro.co. Accessed March 13, 2026.
  4. FDA Guidance for 503A and 503B Compounding Pharmacies. FDA.gov. Updated February 2026.
  5. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989-1002.
  6. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387:205-216.
  7. American Association of Clinical Endocrinologists. Clinical Practice Guidelines for thorough Medical Care of Patients with Obesity. Endocrine Practice. 2024;30:1-48.
  8. Telehealth Market Analysis: GLP-1 Medication Access and Patient Outcomes. Healthcare Analytics Quarterly. 2025;12:23-41.

Medical Disclaimer

This article is for informational purposes only and doesn't constitute medical advice. GLP-1 medications are prescription drugs that require physician supervision and may not be appropriate for all patients. Individual results may vary, and treatment decisions should always be made in consultation with qualified healthcare providers who can assess your specific medical history and needs. Always consult with your physician before starting, stopping, or changing any medication regimen. FormBlends and the authors of this article don't guarantee specific outcomes or results from any treatment discussed. For a complete cost breakdown, see our affordable GLP-1 options.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92First month $99 (semaglutide) or $149 (tirzepatide), then $190 or $239 per month, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Comparison chart - Formblends Vs Hims Vs Ro
Side-by-side comparison of key features and pricing

Medical Disclaimer

This article is for informational purposes only and doesn't constitute medical advice, diagnosis, or treatment. The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician. Individual results vary. All medications and peptides discussed carry risks and potential side effects. Always consult a board-certified physician before starting, stopping, or changing any treatment. FormBlends provides physician-supervised telehealth services. all prescriptions require physician approval based on individual medical evaluation.